GeneralConnection.com ➔ Dictionary
Dictionary Search

savara

Synonyms

Noun

1. Savara

2. Dravidian, Savara

3. South-Central Dravidian

Usage
FDA calls for additional manufacturing data in refusal letter for Savara's respiratory asset - Fierce Pharma
FDA Requests Additional Data for Savara’s MOLBREEVI Application - MSN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Savara Inc. - SVRA - PR Newswire
Savara Re-elects Board Members at Annual Meeting - TipRanks
Savara Enters Into Non-Dilutive Debt Financing for up to $200M With Hercules Capital - Business Wire
BREAKING: Savara Shares Down Over 30%; Securities Fraud - GlobeNewswire
savara elects board members and approves proposals at annual meeting - Investing.com Australia
Savara Reports First Quarter 2025 Financial Results and Provides a Business Update - Business Wire
INVESTOR ALERT: Investigation of Savara Inc. (SVRA) Announced by Holzer & Holzer, LLC - GlobeNewswire
Director Makes Bold Move with Major Savara Stock Purchase - TipRanks
Savara Announces Participation in Jefferies Global Healthcare Conference - Business Wire
Savara Inc. to Present at Jefferies Global Healthcare Conference on June 4, 2025 - MSN
Savara Announces New Employment Inducement Grant - Business Wire
Savara assumed with an Outperform at Oppenheimer - MSN
Savara Reports Fourth Quarter and Year End 2024 Financial Results and Provides Business Update - Business Wire
Savara Reports Third Quarter 2024 Financial Results and Provides Business Update - Business Wire
Savara Initiates Rolling Submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for MOLBREEVI* for the Potential Treatment of Autoimmune Pulmonary Alveolar Proteinosis (aPAP) - Business Wire
FDA refuses to file Savara BLA for Molbreevi - The Pharma Letter
Savara Announces Manuscript on Long-Term Outcomes With Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Published in ERJ Open Research - Business Wire
Savara Announces Participation in Upcoming Healthcare Investor Conferences - Business Wire
Savara stock dives after FDA refuses filing for rare lung disease drug - FirstWord Pharma
Manufacturing issues scupper Savara's lead drug filing - Pharmaphorum
Savara: Make-It-Or-Break-It Molbreevi BLA Filing (NASDAQ:SVRA) - Seeking Alpha
FDA Requests Additional CMC Data for Savara's MOLBREEVI: Q4 2025 Resubmission Planned - Stock Titan
Evercore Downgrades Savara on Manufacturing Concerns for Lung Disease Drug Candidate - Yahoo Finance
Savara Showcases Promising Phase 3 Trial Data for Molgramostim at ATS 2025 - MSN
Savara Inc. Grants Equity Awards to New Employees - MSN
Savara Inc. (SVRA): Analysts See 212% Upside Potential - MSN
FDA Denies Langhorne-Based Savara Application for Rare Lung Disease Treatment - BUCKSCO.Today
Savara marketing application found to be incomplete (SVRA:NASDAQ) - Seeking Alpha
Savara stock plummets after FDA issues 'refuse to file' letter for lead drug candidate Molbreevi - The Business Journals
Savara Completes Submission of the Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for MOLBREEVI* as a Treatment for Autoimmune Pulmonary Alveolar Proteinosis (aPAP) - Yahoo Finance
Savara stock rating cut to Neutral by H.C. Wainwright - Investing.com
Savara sponsors Lifetime talk show episode about rare respiratory disease ahead of FDA submission - Fierce Pharma
SAVARA Earnings Preview: Recent $SVRA Insider Trading, Hedge Fund Activity, and More - Nasdaq
Savara Announces New Data from Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Nebulizer Solution (Molgramostim) in Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Were Presented at the European Respiratory Society (ERS) Congres - Business Wire
Savara Appoints Braden Parker as Chief Commercial Officer, Effective Immediately - Business Wire
Savara Announces Encore Presentation of Results from the Phase 3 IMPALA-2 Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the British Thoracic Society Winter Meeting 2024 - Business Wire
Insider Buying Alert: Joseph Mccracken Acquires Additional Shares of Savara Inc (SVRA) - GuruFocus
Why Is Rare Lung Disease-Focused Savara Stock Trading Lower On Tuesday? - Benzinga
Health Check: How Prudently Does Savara (NASDAQ:SVRA) Use Debt? - simplywall.st
Savara Inc ends sales agreement with Evercore - Investing.com
Clinical Trial Success: Savara's Molgramostim Cuts Rare Lung Disease Burden, Improves Patient Quality of Life - Stock Titan
Oppenheimer Maintains Optimism for Savara (SVRA) Despite Filing Setback | SVRA Stock News - GuruFocus
Savara Inc. (SVRA): Analysts See 212% Upside Potential - Insider Monkey
Oppenheimer Adjusts Price Target on Savara to $5 From $15, Maintains Outperform Rating - marketscreener.com
Savara Faces FDA Setback for MOLBREEVI Application - TipRanks
Wells Fargo Adjusts Savara (SVRA) Price Target Following FDA Feedback | SVRA Stock News - GuruFocus
Savara to Present at the Guggenheim Inaugural Healthcare Innovation Conference - Business Wire
Savara, eyeing rare disease drug submission next year, nabs Orchard's commercial lead to steer launch - Fierce Pharma
Savara (SVRA) Faces FDA Hurdles on Molbreevi Application - GuruFocus
Savara Announces New Employment Inducement Grant | SVRA Stock Ne - GuruFocus
SVRA ALERT: Levi & Korsinsky Investigates Savara Inc. on Behalf of Shareholders Who Lost Money - ACCESS Newswire
SVRA: Savara Downgraded by HC Wainwright & Co. | SVRA Stock News - GuruFocus
H.C. Wainwright Lowers Savara (SVRA) Outlook Following FDA Setback | SVRA Stock News - GuruFocus
Key Analyst Rating Update for Savara (SVRA) | SVRA Stock News - GuruFocus
HC Wainwright & Co. Downgrades Savara (SVRA) - MSN
HC Wainwright Downgrades Savara to Neutral From Buy, Adjusts Price Target to $2 From $6 - marketscreener.com
Wells Fargo Maintains Overweight Rating on Savara (SVRA) with Lower Price Target | SVRA Stock News - GuruFocus
Savara (SVRA) Faces Lowered Price Target Amid BLA Challenges | S - GuruFocus
Savara Receives Refusal to File (RTF) Letter From the U.S. Food and Drug Administration (FDA) for the Biologics License Application (BLA) for MOLBREEVI* to Treat Patients With Autoimmune Pulmonary Alv - GuruFocus
Savara (SVRA) Faces FDA Setback on Molbreevi Therapy | SVRA Stoc - GuruFocus
JMP maintains $9 target on Savara stock, sees FDA nod - Investing.com
Savara director David Ramsay acquires $416,250 in common stock - Investing.com
Savara Announces Participation in Jefferies Global Healthcare Co - GuruFocus
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Savara Inc. - SVRA - FinancialContent
Savara director Joseph McCracken buys $20,825 in stock By Investing.com - Investing.com Nigeria
Savara (SVRA) Stock Rating Maintained, Price Target Adjusted | S - GuruFocus
Savara submits FDA application for aPAP therapy MOLBREEVI - Investing.com
Savara secures $200M loan to support respiratory drug launch - Investing.com
Savara director Joseph McCracken buys $20,825 in stock By Investing.com - Investing.com India
Savara director Joseph McCracken buys $20,825 in stock By Investing.com - Investing.com South Africa
Savara director Joseph McCracken buys $20,825 in stock - Investing.com Australia
Savara Announces New Employment Inducement Grant | SVRA Stock News - GuruFocus
FDA seeks additional data for Savara’s MOLBREEVI BLA By Investing.com - Investing.com Nigeria
Savara Announces Pricing of $100.0 Million Underwritten Offering of Common Stock - Business Wire
Savara Reports First Quarter 2025 Financial Results and Provides a Business Update | SVRA Stock News - GuruFocus
Akshara Brahma: Where every word is a prayer for A.P.’s Savara tribals - The Hindu
Oppenheimer assumes Savara stock at outperform, sets $5 price target By Investing.com - Investing.com UK
Savara Receives Refusal to File (RTF) Letter From the U.S. Food and Drug Administration (FDA) for the Biologics License Application (BLA) for MOLBREEVI* to Treat Patients With Autoimmune Pulmonary Alveolar Proteinosis (autoimmune PAP) - FinancialContent
Savara Announces New Employment Inducement Grant - The Joplin Globe
Savara stock price target cut to $2 at Evercore ISI - Investing.com India
Oppenheimer assumes Savara stock at outperform, sets $5 price target - Investing.com India
BREAKING: Savara Shares Down Over 30%; Securities Fraud Investigation by Block & Leviton ... - Bluefield Daily Telegraph
Savara, Nasty C & Cassper Nyovest Thrill Fans at UCL Final Match Viewing Party - Mpasho
Oppenheimer assumes Savara stock at outperform, sets $5 price target By Investing.com - Investing.com Canada
Savara Announces Participation in Jefferies Global Healthcare Conference - Bluefield Daily Telegraph
Savara stock price target cut to $2 at Evercore ISI By Investing.com - Investing.com UK
Nasty C, Savara set to headline Heineken’s UEFA Champions League Final viewing party: "High energy" - MSN
Guggenheim cuts Savara stock target to $8, maintains Buy rating By Investing.com - Investing.com UK
Savara Is Building the Soundtrack to a New Kenya - OkayAfrica
Savara stock price target cut to $2 at Evercore ISI By Investing.com - Investing.com Canada
Savara Mudigi moved after leading National anthem before Kenya vs Gabon match - MSN
Savara’s SWOT analysis: molbreevi’s potential drives stock outlook - Investing.com India
Manyam collector promotes Savara art by himself learning it - Deccan Chronicle
Savara announces positive phase 3 results for molgramostim in rare lung disease - PMLiVE
"Sianda's" Viral Video Vixen Shares Emotional Journey After Working with Savara - Mpasho
Why Yvonne is managing Savara - Daily Nation
Savara's Personal Choice: Why Yvonne Endo is His Ideal Manager - Mpasho
Savara’s $100M offering; New biotech to test Eisai drug in Ph2 - Endpoints News
Foreign Language Equivalents
Foreign Language Equivalents of 'savara'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
savars,   svara,   savaa,   savar,   savsra,   savata,   savaea,   asvara,   saara,   ssavara,   ssvara,   davara,   savra,   savaraa,   savaar,   savarra,   svaara,   saavra,   aavara,   saavara,   sabara,   avara,   sacara,   savvara,   savaara,   savraa
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z